1. Home
  2. ENTX vs OSS Comparison

ENTX vs OSS Comparison

Compare ENTX & OSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • OSS
  • Stock Information
  • Founded
  • ENTX 2010
  • OSS 1998
  • Country
  • ENTX Israel
  • OSS United States
  • Employees
  • ENTX N/A
  • OSS N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • OSS Computer Manufacturing
  • Sector
  • ENTX Health Care
  • OSS Technology
  • Exchange
  • ENTX Nasdaq
  • OSS Nasdaq
  • Market Cap
  • ENTX 69.6M
  • OSS 62.7M
  • IPO Year
  • ENTX 2018
  • OSS 2018
  • Fundamental
  • Price
  • ENTX $1.79
  • OSS $2.12
  • Analyst Decision
  • ENTX Strong Buy
  • OSS
  • Analyst Count
  • ENTX 1
  • OSS 0
  • Target Price
  • ENTX $10.00
  • OSS N/A
  • AVG Volume (30 Days)
  • ENTX 30.9K
  • OSS 97.1K
  • Earning Date
  • ENTX 05-09-2025
  • OSS 05-08-2025
  • Dividend Yield
  • ENTX N/A
  • OSS N/A
  • EPS Growth
  • ENTX N/A
  • OSS N/A
  • EPS
  • ENTX N/A
  • OSS N/A
  • Revenue
  • ENTX $181,000.00
  • OSS $54,694,359.00
  • Revenue This Year
  • ENTX N/A
  • OSS $9.65
  • Revenue Next Year
  • ENTX N/A
  • OSS $11.43
  • P/E Ratio
  • ENTX N/A
  • OSS N/A
  • Revenue Growth
  • ENTX N/A
  • OSS N/A
  • 52 Week Low
  • ENTX $1.41
  • OSS $1.82
  • 52 Week High
  • ENTX $2.79
  • OSS $4.88
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 49.59
  • OSS 40.60
  • Support Level
  • ENTX $1.50
  • OSS $1.98
  • Resistance Level
  • ENTX $1.84
  • OSS $2.25
  • Average True Range (ATR)
  • ENTX 0.11
  • OSS 0.21
  • MACD
  • ENTX 0.03
  • OSS 0.03
  • Stochastic Oscillator
  • ENTX 85.50
  • OSS 43.83

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bresssner segment.

Share on Social Networks: